IP Library Granted Patent US 10,435,732
Granted Patent B2
US 10,435,732 · App. 15/315,116 · Granted Oct 8, 2019

Method for producing recombinant proteins using recombinant brevibacillus

Inventors: Hiroyuki Kanamaru (Takasago, JP); Teruaki Takesue (Takasago, JP); Osamu Odawara (Takasago, JP); Takeyuki Tsuchidate (Takasago, JP)
Assignee: KANEKA CORPORATION
C12P21/02C12N15/00C12N15/09
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,435,732
App. No.
15/315,116
Granted
Oct 8, 2019
Kind
B2
Abstract

The present invention provides a method for producing a recombinant protein, which can increase the cell growth rate in culture while stably maintaining plasmids in the cells, thereby improving the recombinant protein yield. The present invention provides a method for producing a recombinant protein, including a high-temperature culture step of culturing at 32° C. or higher a Brevibacillus bacterium that contains a gene encoding a recombinant protein, and a low-temperature culture step of culturing the Brevibacillus bacterium at a temperature lower than 32° C. after the high-temperature culture step.

Claims (22)

1. A method for producing a recombinant protein, comprising:

a high-temperature culture step of culturing in a liquid medium at 34° C. or higher and 40° C. or lower a Brevibacillus choshinensis bacterium that contains a gene encoding the recombinant protein;

a temperature shifting step of reducing the temperature of the liquid medium prepared in the high-temperature culture step without replacing the liquid medium, and

a low-temperature culture step of culturing the Brevibacillus choshinensis bacterium in the liquid medium at a temperature at 25° C. or higher and lower than 32° C., which is lower than the culturing temperature in the high-temperature culture step by at least 2° C.-8° C.

2. The method for producing a recombinant protein according to claim 1 ,

wherein a shift from the high-temperature culture step to the low-temperature culture step is made between the early and mid-exponential growth phases of the Brevibacillus bacterium.

3. The method for producing a recombinant protein according to claim 1 ,

wherein the recombinant protein is an antibody-binding protein.

4. The method for producing a recombinant protein according to claim 3 ,

wherein the antibody-binding protein is selected from the E domain, D domain, A domain, B domain, or C domain of Protein A, the C domain or D domain of Protein Cy the B domain of Protein L, proteins comprising the foregoing domains connected together, or functional variants of the foregoing.

5. The method for producing a recombinant protein according to claim, 1 wherein the recombinant protein is a bioactive protein.

6. The method for producing a recombinant protein according to claim 5 ,

wherein the bioactive protein is a peptide hormone or a precursor thereof.

7. The method for producing a recombinant protein according to claim 1 ,

wherein the recombinant protein is an antibody or antibody-like molecule.

8. The method for producing a recombinant protein according to claim 2 , wherein the recombinant protein is an antibody-binding protein.

9. The method for producing a recombinant protein according to claim 8 ,

wherein the antibody-binding protein is selected from the E domain, D domain, A domain, B domain, or C domain of Protein A, the C domain or D domain of Protein Cy the B domain of Protein L, proteins comprising the foregoing domains connected together, or functional variants of the foregoing.

10. The method for producing a recombinant protein according to claim 2 , wherein the recombinant protein is a bioactive protein.

11. The method for producing a recombinant protein according to claim 10 ,

wherein the bioactive protein is a peptide hormone or a precursor thereof.

12. The method for producing a recombinant protein according to claim 2 , wherein the recombinant protein is an antibody or antibody-like molecule.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2017
From: KANAMARU, HIROYUKI; TAKESUE, TERUAKI; ODAWARA, OSAMU; TSUCHIDATE, TAKEYUKI
To: KANEKA CORPORATION
Reel/Frame 041399/0133 →
Priority Claims (1)
JP 2014-118817 · Jun 9, 2014 · national
Continuity (1)
Related Publication 20170211116A1 · Jul 27, 2017